Skip to main content

Table 5 Risk of death and CA-125 changes after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable

HR

95%CI

P

Change of CA-125 concentration

3 months after the treatment (U/ml)

< 0

1.00

0–5

1.62

0.84–3.11

0.15

> 5

3.83

1.47–10.00

0.0062

Change of CA-125 concentration

6 months after the treatment (U/ml)

< 0

1.00

0–5

0.972

0.483–1.956

0.937

> 5

3.1

1.53–6.31

0.0017